Sign in

CIK 0001802768

  • Large accelerated filer

Royalty Pharma plc

Sign in to watch
Ticker
RPRX
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
United Kingdom
Entity type
Operating
Phone
+1 212-883-0200
Business address
110 EAST 59TH STREET, NEW YORK, NY, 10022
  1. 4 Open-market sale EVP, Investments & CLO sold 40,000 shares at an average $43.14 ($1,725,567)
  2. 4 Open-market sale Director sold 120,000 shares at $42.33 ($5,079,924)
  3. 4 Open-market sale EVP, Investments & CLO sold 50,000 shares at an average $43.85 ($2,192,613)
  4. 4 Open-market sale EVP & CFO sold 24,500 shares at $43.47 ($1,065,013)
  5. 4 Open-market sale EVP & CFO sold 5,500 shares at $43.06 ($236,846)
  6. 4 Grant or award Director acquired 913 shares (grant or award)
  7. 4 Grant or award Director acquired 913 shares (grant or award)
  8. 4 Open-market sale EVP & Chief Scientific Officer sold 100,000 shares at $41.23 ($4,122,670)
  9. 4 Open-market sale Director sold 32,593 shares at $41.05 ($1,337,943)
  10. 4 Open-market sale Director sold 211,380 shares at $41.17 ($8,702,113)
  11. 4 Open-market sale Director sold 523,842 shares at an average $41.07 ($21,516,554)
  12. 4 Open-market sale 10% owner sold 267,815 shares at $41.02 ($10,985,798)
  13. 4 Open-market sale Director sold 387,171 shares at an average $41.59 ($16,101,817)
  14. 4 Open-market sale 10% owner sold 387,171 shares at an average $41.59 ($16,101,934)
  15. 4 Open-market sale Director sold 345,014 shares at an average $42.38 ($14,622,925)
  16. 4 Open-market sale 10% owner sold 345,014 shares at an average $42.38 ($14,623,052)
  17. 4 Open-market sale Director sold 100,000 shares at an average $42.30 ($4,230,387)
  18. 4 Open-market sale Director sold 499,500 shares at an average $42.70 ($21,327,337)
  19. 4 Open-market sale 10% owner sold 498,006 shares at an average $42.70 ($21,262,534)
  20. 4 Open-market sale 10% owner sold 1,994 shares at $44.00 ($87,736)

Page 10 of 18 · 342 filings